Balo Andrew K

Average Profitability
227.92%
Insider Buys Quantity
1
Insider Buys Sum
$10,719.60
Insider Sells Quantity
102
Insider Sells Sum
$57.56M

Insider Activity of Balo Andrew K

The largest purchase of all time was on 2008-11-21 and amounted to 7000 shares of DexCom, Inc. for $10,720.

The largest sale of all time was on 2016-06-20 and amounted to 110000 shares of DexCom, Inc. for $4.3M.

Biography of Balo Andrew K

No biography is available at this moment.

2021-09-09SaleDexCom, Inc.
DXCM
*
5,597
0.0057%
$546.78$3.06M-22.49%
2021-08-03SaleDexCom, Inc.
DXCM
*
2,757
0.0028%
$515.87$1.42M-7.51%
2021-07-06SaleDexCom, Inc.
DXCM
*
2,974
0.003%
$430.14$1.28M+11.27%
2021-06-03SaleDexCom, Inc.
DXCM
*
2,391
0.0025%
$375.00$896,625+30.13%
2021-03-10SaleDexCom, Inc.
DXCM
*
5,566
0.0059%
$362.92$2.02M+25.57%
2020-09-15SaleDexCom, Inc.
DXCM
*
5,256
0.0055%
$397.35$2.09M-2.67%
2020-09-09SaleDexCom, Inc.
DXCM
*
4,580
0.0047%
$398.30$1.82M-3.62%
2020-06-15SaleDexCom, Inc.
DXCM
*
6,522
0.0064%
$366.47$2.39M-2.93%
2020-04-15SaleDexCom, Inc.
DXCM
*
6,690
0.0069%
$283.39$1.9M+32.19%
2020-03-11SaleDexCom, Inc.
DXCM
*
8,161
0.0093%
$264.82$2.16M+51.67%
2019-09-18SaleDexCom, Inc.
DXCM
*
2,386
0.0025%
$151.46$361,384+75.87%
2019-09-09SaleDexCom, Inc.
DXCM
*
9,107
0.0104%
$151.56$1.38M+83.24%
2019-09-03SaleDexCom, Inc.
DXCM
*
37
<0.0001%
$170.00$6,290+48.85%
2019-06-05SaleDexCom, Inc.
DXCM
*
7,825
0.0087%
$125.00$978,125+73.16%
2019-03-12SaleDexCom, Inc.
DXCM
*
10,917
0.012%
$142.79$1.56M+7.24%
2018-12-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0057%
$121.23$606,167+21.87%
2018-11-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0058%
$143.13$715,664+4.71%
2018-10-12SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0056%
$124.79$623,934+11.86%
2018-09-14SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,000
0.0057%
$145.17$725,851-2.56%
2018-09-10SaleDexCom, Inc.
DXCM
EVP, Reg. Strategy, Clinical
5,587
0.0063%
$143.76$803,160-3.95%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.